The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients

The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients

Abstract Aim The Xiaoke Pill containing Chinese herb extracts and Glibenclamide, is used in therapy for type 2 diabetes mellitus (T2DM), and is effective in reducing the risk of hypoglycemia and improving diabetes symptoms compared with Glibenclamide. We describe a quantitative proteomics project to...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Xiuying Zhang, Haidan Sun, Sanjoy K. Paul, Quanhui Wang, Xiaomin Lou, Guixue Hou, Bo Wen, Linong Ji, Siqi Liu
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2017-05-01
Sarja:Clinical Proteomics
Aiheet:
Type 2 diabetes mellitus
Hypoglycemia
Proteomics
Glibenclamide
Chinese herb
Linkit:http://link.springer.com/article/10.1186/s12014-017-9154-0

Internet

http://link.springer.com/article/10.1186/s12014-017-9154-0

Samankaltaisia teoksia